TGFBR2 may be a Marker to Predict Breast Cancer Response to Tamoxifen Everyone's Blog Posts - Onco'Zine, 15 Apr 2015 An estimated 30% of patients with estrogen receptor α (ERα)-positive breast cancer being treated with the antiestrogen…